Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
10.6M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
14.1K
-
Shares change
-
-1.77M
-
Total reported value, excl. options
-
$1.44K
-
Value change
-
-$389K
-
Number of sells
-
-16
-
Price
-
$0.10
Significant Holders of Aridis Pharmaceuticals, Inc. - Common Stock (ARDS) as of Q3 2023
18 filings reported holding ARDS - Aridis Pharmaceuticals, Inc. - Common Stock as of Q3 2023.
Aridis Pharmaceuticals, Inc. - Common Stock (ARDS) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.1K shares
of 10.6M outstanding shares and own 0.13% of the company stock.
Largest 10 shareholders include Wealth Architects, LLC (14.1K shares), Cornerstone Wealth Management, LLC (0 shares), GROUP ONE TRADING, L.P. (0 shares), BlackRock Inc. (0 shares), GEODE CAPITAL MANAGEMENT, LLC (0 shares), ICA Group Wealth Management, LLC (0 shares), Roumell Asset Management, LLC (0 shares), WELLS FARGO & COMPANY/MN (0 shares), STATE STREET CORP (0 shares), and Tower Research Capital LLC (TRC) (0 shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.